Skip to search formSkip to main contentSkip to account menu

Factor XI Deficiency

Known as: Rosenthal Syndromes, Plasma Thromboplastin Antecedent Deficiency, F11 DEFICIENCY 
A hereditary deficiency of blood coagulation factor XI (also known as plasma thromboplastin antecedent or PTA or antihemophilic factor C) resulting… 
National Institutes of Health

Related topics

Related topics

18 relations
Congenital disorder of glycosylation type 1ACongenital disorder of glycosylation type 1BCongenital disorder of glycosylation type 1CF11 gene

Broader (1)

Hemophilia A

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Suppression of Infection by Famine and Its Activation by Refeeding—a Paradox?
Together, famine and infection have stalked the land since earliest times. Are they inseparable twins or is their liaison… 
Highly Cited
2009
Highly Cited
2009
Injection, transport, absorption and phosphorescence properties of a series of blue-emitting Ir(III) emitters in OLEDs: a DFT and time-dependent DFT study.
Quantum-chemistry methods were explored to investigate the electronic structures, injection and transport properties, absorption… 
Highly Cited
2008
Highly Cited
2008
Evidence for stage-specific modulation of specific microRNAs (miRNAs) and miRNA processing components in zygotic embryo and female gametophyte of loblolly pine (Pinus taeda).
MicroRNAs (miRNAs) are known to regulate plant development, but have not been studied in gymnosperm seed tissues. The presence… 
Highly Cited
2008
Highly Cited
2008
Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency
Summary.  Factor XI (FXI) deficiency is associated with bleeding after invasive procedures. Risks of human plasma‐derived FXI… 
Highly Cited
2000
Highly Cited
2000
Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy…
Highly Cited
1997
Highly Cited
1997
Absence of Inhibitors in Previously Untreated Patients with Severe Haemophilia A after Exposure to a Single Intermediate Purity Factor VIII Product
Summary Use of high purity and recombinant factor VIII (FVIII) concentrates has been thought to be associated with an increased… 
Highly Cited
1996
Highly Cited
1996
High incidence of anti‐FVIII antibodies against non‐coagulant epitopes in haemophilia A patients: a possible role for the half‐life of transfused FVIII
The occurrence of antibodies (Abs) capable of inhibiting factor VIII (FVIII) coagulant activity is a severe complication in… 
Highly Cited
1994
Highly Cited
1994
Haemophilia A diagnosis by simultaneous analysis of two variable dinucleotide tandem repeats within the factor VIII gene
Summary. Haemophilia A is a bleeding disorder caused by defects in the gene coding for the co‐factor, factor VIII (FVIII). The… 
Highly Cited
1991
Highly Cited
1991
Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity
Summary. Carrier and prenatal diagnosis based on the identification of the gene defect (direct diagnosis) increases the… 
Highly Cited
1959
Highly Cited
1959
Hageman Trait and PTA Deficiency; the Role of Contact of Blood with Glass
ROSENTHAL (1955) and Rosenthal, Dreskin and Rosenthal (1955) described a third prothromboplastic factor, plasma thromboplastin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)